Deva Holding A.S. (IST:DEVA)

Market Cap	14.09B
Revenue (ttm)	15.03B
Net Income (ttm)	-27.20M
Shares Out	200.02M
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	0.29 (0.41%)
Ex-Dividend Date	n/a

Volume	532,788
Average Volume	722,108
Open	70.50
Previous Close	70.45
Day's Range	69.70 - 70.55
52-Week Range	51.00 - 81.30
Beta	-0.60
RSI	52.17
Earnings Date	Nov 4, 2025

About Deva Holding A.S.

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, urinary syste...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1958
• Employees: 3,063
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: DEVA

Financial Performance

In 2024, Deva Holding A.S.'s revenue was 15.46 billion, a decrease of -5.50% compared to the previous year's 16.36 billion. Earnings were 69.42 million, a decrease of -98.58%.